US 12383572
Administration of an anti-activin-a compound to a subject
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12383572 (Administration of an anti-activin-a compound to a subject) held by Atara Biotherapeutics, Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atara Biotherapeutics, Inc.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K31/704, A61K31/7068